Biologics

Anika launched Tactoset, its new surgical therapy for bone repair procedures at the Orthopaedic Summit 2019: Evolving Techniques, which is taking place in Las Vegas, Dec. 11-14.

While biologic-based treatments have loads of promise when it comes to orthopedics, illegal actors are tarnishing the space and promoting false narratives that hurt scientific advances. 

ElevateBio appointed Melissa Carpenter, PhD, as chief scientific officer of regenerative medicine Dec. 9.

The FDA cleared EmCyte's Progenikine Concentrating System for adipose lipoplasty for procedures in several specialties including neurosurgery and orthopedics.

Rochester, Minn.-based Mayo Clinic is in the midst of analyzing a stem cell therapy for spine injuries, the Minneapolis StarTribune reports.

The Arthroscopy Association of North America, American Orthopaedic Society for Sports Medicine, International Cartilage Repair Society and ON Foundation have partnered to form The Biologics Alliance.

The U.S. Department of Defense's Peer Reviewed Orthopaedic Research Program recently provided the University of Arkansas at Little Rock with a $750,000 grant to study the NuCress scaffold's ability to combat infection while regenerating bone, reports Newswise.

SpineOvations initiated a pilot clinical study of DiscSeal in patients suffering from lumbar spine pain after recently receiving Australian regulatory approval.

The American Academy of Orthopaedic Surgeons is investing in research and development for biologics in a five-year initiative announced on Nov. 20.

The FDA approved Cerapedics premarket approval supplement for i-Factor in anterior cervical discectomy and fusion procedures in patients with degenerative disc disease.